Learning abilities, NGF and BDNF brain levels in two lines of TNF-α transgenic mice, one characterized by neurological disorders, the other phenotypically normal

Brain Research

Volumn 840, Issue 1-2, 1999, Pages 125-137

  Aloe, Luigi ^a   Properzi, Francesca ^a   Probert, Lesley ^b   Akassoglou, Katerina ^b   Kassiotis, George ^b   Micera, Alessandra ^a   Fiore, Marco ^a  

^a CNR   (Italy)

^b HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

Behavior; CNS inflammation; Cytokine; Demyelination; Inflammation; Learning; TNF ; Transgenic mice

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOKINE; NERVE GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATION; GENE OVEREXPRESSION; INFLAMMATION; LEARNING; MAZE TEST; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAZE LEARNING; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; NERVE GROWTH FACTOR; NERVOUS SYSTEM DISEASES; REFERENCE VALUES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033523473     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01748-5     Document Type: Article

References (53)

1. Akassoglou K., Probert L., Kontogeorgos G., Kollias G. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J. Immunol. 158:1997;438-445.
2. Akassoglou K., Bauer J., Kassiotis G., Pasparakis M., Lassmann H., Kollias G., Probert L. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: Models for multiple sclerosis with primary oligodendropathy. Am. J. Pathol. 153:1998;801-813.
3. Aloe L., Levi-Montalcini R. Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Res. 133:1977;358-366.
4. Aloe L., Fiore M., Probert L., Turrini P., Kollias G., Tirassa P. Overexpression of tumour necrosis factor-alpha in the brain of transgenic mice differentially alters nerve growth factor levels and acetylcholine transferase activity. Cytokine. 11:1999;45-54.
5. Aloe L., Alleva E., De Simone R. Changes of NGF level in mouse hypothalamus following intermale aggressive behavior: biological and immunohistochemical evidence. Behav. Brain Res. 39:1990;53-61.
6. Aloe L., Iannitelli A., Bersani G., Alleva E., Angelucci F., Maselli P., Manni L. Haloperidol administration in humans lowers plasma NGF levels: evidence that sedation induces opposite effects to arousal. Neuropsychobiology. 37:1997;65-68.
7. Aloe L., Skaper S.D., Leon A., Levi-Montalcini R. Nerve growth factor and autoimmune diseases. Autoimmunity. 19:1994;141-150.
8. Bianchi M., Sacerdote P., Panerai A. Cytokines and cognitive function in mice. Biol. Signals Recept. 7:1998;45-54.
9. Bjugstad K.B., Flitter W.D., Garland W.A., Su G.C., Arendash G.W. Preventive actions of a synthetic antioxidant in a novel animal model of AIDS dementia. Brain Res. 795:1998;349-357.
10. Bracci-Laudiero L., Aloe L., Levi-Montalcini R., Buttinelli C., Schilter D., Gillessen S. Multiple sclerosis patients express increased levels of β-nerve growth factor in cerebrospinal fluid. Neurosci. Lett. 147:1992;9-12.
11. Bruce A.J., Boling W., Kindy M.S., Peschon J., Kraemer P.J., Carpenter M.K., Holtsberg F.W., Mattson M.P. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat. Med. 2:1996;788-794.
12. Bruni A., Bigon E., Boarato E., Mietto L., Leon A., Toffano G. Interaction between nerve growth factor and lysophosphatidylserine on rat peritoneal mast cells. FEBS Lett. 138:1982;190-192.
13. Bull H.A., Leslie T.A., Chopra S., Dowd P.M. Expression of nerve growth factor receptors in cutaneous inflammation. Br. J. Dermatol. 139:1998;776-783.
14. Chen L., Seaber A.V., Wong G.H.W., Urbaniak J.R. Tumor necrosis factor promotes motor functional recovery in crushed peripheral nerve. Neurochem. Int. 29:1996;197-203.
15. Cheng B., Christakos S., Mattson M.P. Tumor necrosis factor protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron. 12:1994;139-153.
16. A.C. Cuello, Brain Microdissection Techniques. IBRO Handbook Series, Wiley, 1983.
17. Dawson D.A., Martin D., Hallenbeck J.M. Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rats. Neurosci Lett. 218:1996;41-44.
18. Dell'Omo G., Wolfer D., Alleva E. HP Lipp Developmental exposure to ozone induces subtle changes in swimming navigation of adult mice. Toxicol. Lett. 15:1995;91-99.
19. Eddy L.J., Goeddel D.V., Wong G.H. Tumor necrosis factor-α pretreatment is protective in a rat model of myocardial ischemia-reperfusion injury. Biochem. Biophys. Res. Commun. 184:1992;1056-1059.
20. Fiore M., Probert L., Kollias G., Akassoglou K., Alleva E., Aloe L. Neurobehavioral alterations in developing transgenic mice expressing TNF-α in the brain. Brain Behav. Immun. 10:1996;126-138.
21. Fisher W., Wiktorin K., Bjorklund A., Williams L.R., Varon S., Gage F.H. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature. 329:1987;65-68.
22. Gadient R.A., Cron K.C., Otten U. Interleukin-1β and tumor necrosis factor-α synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes. Neurosci. Lett. 117:1990;335-340.
23. Hattori A., Iwasaki S., Murase K., Tsujimoto M., Sato M., Hayashi K., Kohno M. Tumor necrosis factor is marked synergistic with IL-β and Interferon-γ in stimulating the production of NGF in fibroblast. FEBS Lett. 340:1994;177-180.
24. Hattori A., Tanaka E., Murase B.K., Ishida N., Chatani Y., Tsujimoto M., Hayashi K., Kohno M. Tumor necrosis factor stimulates the synthesis and secretion of biologically active nerve growth factor in non-neuronal cells. J. Biol. Chem. 268:1993;2577-2582.
25. Kerschensteiner M., Gallmeier E., Behrens L., Leal V.V., Hoppe E., Oropeza-Wekerle R.L., Bartke I., Stadelmann C., Lassmann H., Wekerle H., Hohlfeld G.K., Risgeld T., Klinkert W.E., Kolbeck R. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? Exp. Med. 189:1999;865-870.
26. Lambiase A., Bracci-Laudiero L., Bonini S., Bonini S., Starace G., D'Elios M.M., De Carli M., Aloe L. Human CD4+ T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors. J. Allergy Clin. Immunol. 100:1997;408-414.
27. Levi-Montalcini R. The nerve growth factor 35 years later. Science. 237:1987;1154-1162.
28. Li A.K., Koroly M.J., Schattenkerk M.E., Malt R.A., Young M. Nerve growth factor: acceleration of the rate of wound healing in mice. Proc. Natl. Acad. Sci. U.S.A. 77:1980;4379-4381.
29. Liu T., Clark R.K., McDonnell P.C., Young P.R., White R.F., Barone F.C., Feuerstein G.Z. Tumor necrosis factor-α expression in ischemic neurons. Stroke. 25:1994;1481-1488.
30. Lu H., Richardson P.M. Inflammation near the nerve cell body enhances axonal regeneration. J. Neurosci. 11:1991;972-978.
31. Merrill J.E. Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological. Dev. Neurosci. 14:1992;1-10.
32. Merrill J.E., Benveniste E.N. Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 19:1996;331-338.
33. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods. 11:1984;47-60.
34. Munoz-Fernandez M.A., Fresno M. The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog. Neurobiol. 56:1998;307-340.
35. Old L.J. Tumor necrosis factor. Sci. Am. 258:1988;59-75.
36. Otten U., Ehrhard P., Peck R. Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 86:1989;10059-10063.
37. Pearce F.L., Thompson H.L. Some characteristics of histamine secretion from rat peritoneal mast cells stimulated with nerve growth factor. J. Physiol. 372:1986;379-393.
38. Probert L., Akassoglou K., Kassiotis G., Pasparakis M., Alexopoulou L., Kollias G. TNF-alpha transgenic and knockout models of CNS inflammation and degeneration. J. Neuroimmunol. 72:1997;137-141.
39. Probert L., Selmaj K. TNF and related molecules: trends in neuroscience and clinical applications. J. Neuroimmunol. 72:1997;113-117.
40. Probert L., Akassoglou K., Pasparakis M., Kontogeorgos G., Kollias G. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor α Proc. Natl. Acad. Sci. U.S.A. 92:1995;11294-11298.
41. Rothwell N.J., Luheshi G.N. Brain TNF: damage limitation or damaged reputation? Nat. Med. 7:1996;746-747.
42. Scott S.A., Crutcher K.A. Nerve growth factor and Alzheimer's disease. Rev. Neurosci. 5:1994;179-211.
43. Shadiack A.M., Vaccariello S.A., Sun Y., Zigmond R.E. Nerve growth factor inhibits sympathetic neurons' response to an injury cytokine. Proc. Natl. Acad. Sci. USA. 95:1998;7727-7730.
44. Steiner P., Pfeilschifter J., Boeckh C., Radeke H., Otten U. Interleukin-1 beta and tumor necrosis factor-alpha synergistically stimulate nerve growth factor synthesis in rat mesangial cells. Am. J. Physiol. 261:1991;F792-F798.
45. Tam S.Y., Tsai M., Yamaguchi M., Yano K., Butterfield J.H., Galli S.J. Expression of functional TrkA receptor tyrosine kinase in the HMC-1 human mast cell line and in human mast cells. Blood. 90:1997;1807-1820.
46. Tchelingerian J.L., Vignais L., Jacque C. TNF-α gene expression is induced in neurons after hippocampal lesion. NeuroReport. 5:1994;585-588.
47. Thoenen H., Bandtlow C., Heumann R. The physiological function of nerve growth factor in the central nervous system: comparison with the periphery. Rev. Physiol. Biochem. Pharmacol. 109:1987;146-171.
48. Torcia M., Bracci-Laudiero L., Lucibello M., Nencioni L., Labardi D., Rubartelli A., Cozzolino F., Aloe L., Garaci E. Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell. 85:1996;345-356.
49. E. Vigneti, L. Bracci-Laudiero, L. Aloe, Production and characterization of a monoclonal antibody against nerve growth factor (NGF) which recognizes rodent and human NGF. In: F. Malavasi, A. Albertini, C.P. Terhost (Eds.), Generation of antibodies by cell and gene immortalization. Year Immunol, Basel, Karger. Vol. 7, 1993, pp. 146-149.
50. Vilcek J., Lee T.H. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J. Biol. Chem. 266:1991;7313-7316.
51. Weskamp G., Otten U. An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and peripheral tissues. J. Neurochem. 48:1987;1779-1786.
52. R.R. Wilcox, New statistical procedures for the social sciences. Erlbaum: Hillsdale, NJ, 1987.
53. Woolf C.J., Allchorne A., Safieh-Garabedian B., Poole S. Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br. J. Pharmacol. 121:1997;417-424.